Ordering Recommendation

Preferred test to follow-up presumptive results. For general screening, Tapentadol Urine Screen with Reflex to Quantitation (2012294) is preferred.


Quantitative Liquid Chromatography-Tandem Mass Spectrometry


Sun, Wed, Fri


1-6 days

New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation

Random urine.

Specimen Preparation

Transfer 2 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 1 mL)

Storage/Transport Temperature

Room temperature.

Unacceptable Conditions

Specimens exposed to repeated freeze/thaw cycles.


Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years.

Reference Interval

Effective August 17, 2015

Drugs Covered Cutoff Concentrations
Tapentadol 50 ng/mL
Tapentadol glucuronide 100 ng/mL
Tapentadol-O-sulfate (qualitative only) 100 ng/mL
N-desmethyltapentadol (qualitative only) 100 ng/mL

Interpretive Data

Methodology: Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Positive Cutoff:

           Tapentadol: 50 ng/mL
           Tapentadol glucuronide: 100 ng/mL
           Tapentadol-O-sulfate: 100 ng/mL
           N-desmethyltapentadol: 100 ng/mL
For medical purposes only; not valid for forensic use.

The presence of metabolite(s) without parent drug is not uncommon and may indicate use over the prior week.

The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.

Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Hotline History
CPT Codes

80372 (Alt code: G0480)

Component Test Code* Component Chart Name LOINC
2003129 Tapentadol, Urn, Quant 65807-0
2003130 N-desmethyltapentadol, Urn, Qual
2005875 Tapentadol glucuronide, Urn, Quant
2005879 Tapentadol-O-sulfate, Urn, Qual
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
  • Nucynta
  • Tapentadol, Quantitative, Urine
  • urine tapentadol concentration
Tapentadol and Metabolite, Urine, Quantitative